Amanda Wagner, MD
Obstetrics & Gynecology · Stayton, ORNPI 1235457359
Payments from drug & device makers
Across 87 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$549
- Daiichi Sankyo Inc.$112
- Pfizer$109
- Channel Medsystems, Inc.$104
- Intuitive Surgical$103
- Axonics, Inc.$73
- plus $685 from 21 others
What the payments were for
- Food & beverage$1,735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $549 |
| Daiichi Sankyo Inc. | 6 | $112 |
| Pfizer | 8 | $109 |
| Channel Medsystems, Inc. | 1 | $104 |
| Intuitive Surgical | 2 | $103 |
| Axonics, Inc. | 4 | $73 |
| Shield Therapeutics Inc | 1 | $60 |
| Mayne Pharma Commercial LLC | 3 | $59 |
| Merck | 4 | $55 |
| Organon | 2 | $50 |
| Roche Diagnostics Corporation | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Avion Pharmaceuticals | 3 | $40 |
| Myriad Women's Health, Inc. | 1 | $40 |
| Covidien LP | 1 | $37 |
| Sage Therapeutics, LLC | 2 | $32 |
| Novo Nordisk | 2 | $30 |
| Bayer | 2 | $29 |
| Medtronic | 1 | $21 |
| Scynexis, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
How this compares
$1,735 in reported general payments places this provider in the 80th percentile of 480 obstetrics & gynecology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 45 | $3,420 |
| Clobetasol Propionate | 18 | $513 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $184 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Stayton
- Jeffrey JensenPortland$1.2M
- Alison EdelmanPortland$963K
- Nora DotyPortland$317K
- Maria RodriguezPortland$241K
- Alyssa ColwillPortland$117K
- Audra Norris-JacobGresham$94K
- Heather MackaySalem$86K
- Paula BednarekPortland$81K
- Amanda ClarkPortland$65K
- Robert HarderSalem$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.